SELECT: a 10% reduction in body weight with GLP-1 receptor agonists improves kidney outcomes in overweight and obese patients without diabetes.

Marieta P TheodorakopoulouMarius MiglinasMorten Buus Jørgensen

Published in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2024)

Keyphrases

body weight
end stage renal disease
ejection fraction
type diabetes
newly diagnosed
chronic kidney disease
peritoneal dialysis
glycemic control
patient reported outcomes
weight loss
insulin resistance